iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Sees Large Growth in Short Interest

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the target of a large growth in short interest during the month of February. As of February 13th, there was short interest totaling 4,809 shares, a growth of 34.1% from the January 29th total of 3,586 shares. Based on an average daily volume of 620 shares, the short-interest ratio is presently 7.8 days. Approximately 3.2% of the shares of the company are short sold. Approximately 3.2% of the shares of the company are short sold. Based on an average daily volume of 620 shares, the short-interest ratio is presently 7.8 days.

iShares Neuroscience and Healthcare ETF Stock Down 1.1%

NYSEARCA IBRN traded down $0.35 during trading on Monday, hitting $31.73. The company’s stock had a trading volume of 1,875 shares, compared to its average volume of 2,202. The firm has a 50 day moving average price of $32.33 and a 200 day moving average price of $29.66. The firm has a market cap of $4.76 million, a P/E ratio of 15.61 and a beta of 0.93. iShares Neuroscience and Healthcare ETF has a 52 week low of $17.86 and a 52 week high of $37.00.

iShares Neuroscience and Healthcare ETF Company Profile

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.